Diseases of the cardiovascular system Hypertension--II.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001627:Bethanidine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003647:Debrisoquin / Q000627:therapeutic use; D003981:Diazoxide / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D008750:Methyldopa / Q000008:administration & dosage / Q000627:therapeutic use; D008517:Phytotherapy; D010879:Piperazines / Q000627:therapeutic use; D010946:Plants, Medicinal; D011799:Quinazolines / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D010879:Piperazines; D011799:Quinazolines; D006830:Hydralazine; D008750:Methyldopa; D003000:Clonidine; D003981:Diazoxide; D001627:Bethanidine; D003647:Debrisoquin; D006145:Guanethidine